References – 2022

Medina-Pestana J, Cristelli MP, Viana LA, Foresto RD, Requião-Moura LR, Tedesco-Silva H, Covas DT. Clinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant Recipients. Transplantation. 2022 Jan 1;106(1):e95-e97.

Zucherato VS, Evaristo M, Santos EV, Mello R, Donizetti EC,Covas DT, et al. SARS-CoV-2 serological cross-reactivity testing in Brazilian blood donors, October-December, 2019. J Infect. 2022 Jan 1;S0163-4453(21)00660-5.

Alves-Silva AB, Fenerich BA, Fonseca NP, Fernandes JC, Coelho-Silva JL, Rego EM, et al. Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model. Invest New Drugs. 2022 Jan 11. Online ahead of print.

Rodrigues ES, Salustiano S, Santos EV, Slavov SN, Picanço-Castro V, Covas DT, et al. Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR. J Neurovirol. 2022 Jan 13. Online ahead of print.

Roversi FM, Bueno MLP, da Silva JAF, Assis-Mendonça GR, Torello CO, Rego EM, et al. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. Cancer Immunol Immunother. 2022 Jan 18. Online ahead of print.

Siena ÁDD, Barros II, Storti CB, de Biagi Júnior CAO, da Costa Carvalho LA, Silva WA Jr, et al. Upregulation of the novel lncRNA U731166 is associated with migration, invasion and vemurafenib resistance in melanoma. J Cell Mol Med. 2022 Jan 18. Online ahead of print.

Biselli JM, Zampieri BL, Biselli-Chicote PM, de Souza JES, Goloni-Bertollo EM, da Silva WA Jr, et al. Differential microRNA expression profile in blood of children with Down syndrome suggests a role in immunological dysfunction. Hum Cell. 2022 Jan 20. Online ahead of print.

Batah SS, Benatti MN, Siyuan L, Telini WM, Barboza JO, Calado RT, et al. COVID-19 bimodal clinical and pathological phenotypes. Clin Transl Med. 2022 Jan;12(1):e648.

Slavov SN, Bezerra RDS, Rodrigues ES, Santos EV,Calado RT, Dimas DT, et al. Genomic monitoring of the SARS-CoV-2 B1.1.7 (WHO VOC Alpha) in the Sao Paulo state, Brazil. Virus Res. 2022 Jan 15;308:198643.

De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Covas DT, Calado RT, et al. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerg Infect Dis. 2022 Jan 26;28(3).

Kashima S, Slavov SN, Giovanetti M, Rodrigues ES, Covas DT, Calado RT, et al. Introduction of SARS‐CoV‐2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil.J Med Virol. 2022;94:1206‐1211

Elias MC, Ranieri A, Ribeiro G, Covas DT, Sampaio SC. A Sequencing Network that São Paulo State population deserves: a successful case of supporting Public Health. Lancet Reg Health Am. 2022;5: 100180.

Bezerra RDS, Ximenez JPB, Giovanetti M, Zucherato VS, Covas DT, Slavov SN, et al. Metavirome composition of brazilian blood donors positive for the routinely tested blood-borne infections. Virus Res. 2022 Jan 25;198689. Online ahead of print.

Hirabara SM, Serdan TDA, Gorjao R, Masi LN, Pithon-Curi TC, Covas DT, Curi R, Durigon EL. SARS-COV-2 Variants: Differences and Potential of Immune Evasion. Front Cell Infect Microbiol. 2022 Jan 18;11:781429.

Terra POC, Donadel CD, Oliveira LC, Menegueti MG, Auxiliadora-Martins M, Calado RT, De Santis GC. Neutrophil-to-lymphocyte ratio and D-dimer are biomarkers of death risk in severe COVID-19: A retrospective observational study. Health Sci Rep. 2022 Feb 9;5(2):e514.

Pires da Silva BGP, Fonseca NP, Catto LFB, Pereira GC, Calado RT. The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center. Ann Hematol. 2022 Feb 18. 

Lima ARJ, Ribeiro G, Viala VL, Lima LPO, Martins AJ, Covas DT, et. al. SARS-COV-2 GENOMIC MONITORING IN THE STATE OF SÃO PAULO UNVEILS TWO EMERGING AY.43 SUBLINEAGES. J Med Virol. 2022 Mar 1.

Lima K, Vicari HP, Carlos JAEG, da Silva JCL, Figueiredo-Pontes LL, Rego EM, Machado-Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):124-127.

Erdem A, Marin S, Pereira-Martins DA, Cortés R, Cunningham A, Rego EM, et. al. The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia. Nat Commun. 2022 Mar 1;13(1):1105.

Plaça JR, Diepstra A, Los T, Mendeville M, Seitz A, da Silva WA Jr, et. al. Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma. Cancers (Basel). 2022 Mar 5;14(5):1346.

Yépez Y, Marcano-Ruiz M, Bezerra RS, Fam B, Ximenez JP, Silva WA Jr, Bortolini MC. Evolutionary history of the SARS-CoV-2 Gamma variant of concern (P.1): a perfect storm. Genet Mol Biol. 2022 Mar 9;45(1):e20210309.

Song ATW, Rocha V, Mendrone-Júnior A, Calado RT, De Santis GC, Benites BD, et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Reg Health Am. 2022 Jun;10:100216.

Medina-Pestana J, Covas DT, Viana LA, Dreige YC, Nakamura MR, Lucena EF, et al. Inactivated Whole-virus Vaccine Triggers Low Response Against SARS-CoV-2 Infection Among Renal Transplant Patients: Prospective Phase 4 Study Results. Transplantation. 2022 Apr;106(4):853–61.

Semeano AT, Tofoli FA, Corrêa-Velloso JC, de Jesus Santos AP, Oliveira-Giacomelli Á, Cardoso RR, et al. Effects of Magnetite Nanoparticles and Static Magnetic Field on Neural Differentiation of Pluripotent Stem Cells. Stem Cell Rev and Rep [Internet]. 2022 Mar 24 [cited 2022 Mar 28]; Available from: https://link.springer.com/10.1007/s12015-022-10332-0

Carvalho LAC, Queijo RG, Baccaro ALB, Siena ÁDD, Silva WA, Rodrigues T, et al. Redox-Related Proteins in Melanoma Progression. Antioxidants. 2022 Feb 22;11(3):438.

Silva WF, Amano MT, Perruso LL, Cordeiro MG, Kishimoto RK, de Medeiros Leal A, et al. Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation. Hematology. 2022 Dec 31;27(1):396–403.

Rossetti R, Brand H, Lima SCG, Furtado IP, Silveira RM, Fantacini DMC, et al. Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer. Immunotherapy Advances. 2022;2(1).

Santana-Gonçalves M, Zanin-Silva D, Henrique-Neto Á, Moraes DA, Kawashima-Vasconcelos MY, Lima-Júnior JR, et al. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal. 2022 Mar.

Martins-da-Silva A, Baroni M, Salomão KB, das Chagas PF, Bonfim-Silva R, Geron L, et al. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma. Cell Mol Neurobiol. Cell Mol Neurobiol. 2022 Apr 2.

Giovanetti M, Slavov SN, Fonseca V, Wilkinson E, Tegally H, Patané JSL, et al. Genomic epidemiology reveals the impact of national and international restrictions measures on the SARS-CoV-2 epidemic in Brazil. Genetic and Genomic Medicine. 2022 Mar.

Giovanetti M, Fonseca V, Wilkinson E, Tegally H, San EJ, Althaus CL, et al. Replacement of the Gamma by the Delta variant in Brazil: Impact of lineage displacement on the ongoing pandemic. Virus Evolution. 2022 Apr 1;8(1):veac024.

Botosso VF, Jorge SAC, Astray RM, de Sá Guimarães AM, Mathor MB, de Carneiro P dos S, et al. Anti-SARS-CoV-2 equine F(Ab′)2 immunoglobulin as a possible therapy for COVID-19. Sci Rep. 2022 Mar 10;12(1):3890.

Erdem A, Marin S, Pereira-Martins DA, Geugien M, Cunningham A, Pruis MG, Weinhäuser I, et al. Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability. Nat Commun. 2022 Apr 19;13(1):2013.

Recchia K, Machado LS, Botigelli RC, Pieri NCG, Barbosa G, de Castro RVG, et al. In vitro induced pluripotency from urine-derived cells in porcine. World J Stem Cells. 2022 Mar 26;14(3):231-244.

Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, et al. Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia. N Engl J Med. 2022 Apr 21;386(16):1519-1531.

Pontelli MC, Castro IA, Martins RB, La Serra L, Veras FP, Nascimento DC, et al. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. J Mol Cell Biol. 2022 Apr 22:mjac021.

De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerg Infect Dis. 2022 May;28(5):1083-1084.

Medina-Pestana J, Covas DT, Viana LA, Dreige YC, Requião-Moura LR, Nakamura MR, et al. Homologous Third Dose of Inactivated Whole-virion Vaccine Fails to Elicit a Robust Immune Response Among Kidney Seronegative Transplant Recipients. Transplantation. 2022 May 1;106(5):e284-e285.

Jarduli-Maciel LR, de Azevedo JTC, Clave E, Costa TCM, Arruda LCM, Fournier I, et al. Allogeneic haematopoietic stem cell transplantation resets T- and B-cell compartments in sickle cell disease patients.Clin Transl Immunology. 2022 Apr 23;11(4):e1389.